Literature DB >> 12446472

Pyrosequencing as an alternative to single-strand conformation polymorphism analysis for detection of N-ras mutations in human melanoma metastases.

Asa Sivertsson1, Anton Platz, Johan Hansson, Joakim Lundeberg.   

Abstract

BACKGROUND: Mutations in codons 12, 13, and 61 of the N-ras gene are common alterations in cutaneous malignant melanoma. We evaluated pyrosequencing, a simple and rapid method used mainly for single-nucleotide polymorphism analysis, as a possible alternative to single-strand conformation polymorphism (SSCP) analysis and sequencing of N-ras.
METHODS: We evaluated the sensitivity and accuracy of the pyrosequencing method for identification of mutations in N-ras codons 12, 13, and 61. Nucleotide dispensation orders were created to produce distinct pyrogram peak profiles for the most frequent mutations in codon 61 and codons 12 and 13, respectively.
RESULTS: The detection limits for the two most common codon 61 mutations found in malignant melanoma, which code for Arg and Lys, were 30% and 15%, respectively. To evaluate the pyrosequencing method on clinical samples, we performed a parallel analysis of 82 melanoma metastases using SSCP analysis and pyrosequencing. All mutations detected by SSCP analysis and confirmed by sequencing were also correctly identified by pyrosequencing. Codon 61 mutations were identified in 26 of the 82 samples (32%), whereas no mutations were found in codons 12 and 13. Four types of codon 61 mutations, Arg (17%), Lys (10%), Leu (4%), and His (1%), were identified.
CONCLUSION: Pyrosequencing is an attractive alternative to SSCP analysis for N-ras mutation detection in malignant melanoma tumor samples because it displays the same sensitivity and accuracy as SSCP analysis and is simple and rapid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446472

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  High-throughput homogeneous mass cleave assay technology for the diagnosis of autosomal recessive Parkinson's disease.

Authors:  Christopher Schroeder; Michael Walter; Daniela Berg; Petra Leitner; Peter Bauer; Zacharias Kohl; Jürgen Winkler; Olaf Riess; Michael Bonin
Journal:  J Mol Diagn       Date:  2008-04-10       Impact factor: 5.568

2.  Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

Authors:  Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Liying Yan; Mami Cantor; Chungdak Namgyal; Mari Mino-Kenudson; Gregory Y Lauwers; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

3.  Association between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma.

Authors:  Shaowei Wu; Helen Kuo; Wen-Qing Li; Alvaro Laga Canales; Jiali Han; Abrar A Qureshi
Journal:  Cancer Causes Control       Date:  2014-07-22       Impact factor: 2.506

4.  CXCR4 pathway associated with family history of melanoma.

Authors:  Wen-Qing Li; Jiali Han; Hans R Widlund; Mick Correll; Yaoyu E Wang; John Quackenbush; Martin C Mihm; Alvaro Laga Canales; Shaowei Wu; Todd Golub; Yujin Hoshida; David J Hunter; George Murphy; Thomas S Kupper; Abrar A Qureshi
Journal:  Cancer Causes Control       Date:  2013-10-25       Impact factor: 2.506

5.  Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site.

Authors:  Anton Platz; Suzanne Egyhazi; Ulrik Ringborg; Johan Hansson
Journal:  Mol Oncol       Date:  2007-12-28       Impact factor: 6.603

6.  Construction of a multiplex mutation hot spot PCR panel: the first step towards colorectal cancer genotyping on the GS Junior platform.

Authors:  Bálint Péterfia; Alexandra Kalmár; Árpád V Patai; István Csabai; András Bodor; Tamás Micsik; Barnabás Wichmann; Krisztina Egedi; Péter Hollósi; Ilona Kovalszky; Zsolt Tulassay; Béla Molnár
Journal:  J Cancer       Date:  2017-01-12       Impact factor: 4.207

7.  KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells.

Authors:  Marzena Anna Lewandowska; Wojciech Jóźwicki; Bogdan Żurawski
Journal:  Mol Diagn Ther       Date:  2013-06       Impact factor: 4.074

8.  N-ras mutation detection by pyrosequencing in adult patients with acute myeloid leukemia at a single institution.

Authors:  Ji Hun Jeong; Soon Ho Park; Mi Jung Park; Moon Jin Kim; Kyung Hee Kim; Pil Whan Park; Yiel Hea Seo; Jae Hoon Lee; Jinny Park; Junshik Hong; Jeong Yeal Ahn
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

9.  RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures.

Authors:  Francianne Gomes Andrade; Juliana Montibeller Furtado-Silva; Bruno Alves de Aguiar Gonçalves; Luiz Claudio Santos Thuler; Thayana Conceição Barbosa; Mariana Emerenciano; André Siqueira; Maria S Pombo-de-Oliveira
Journal:  BMC Cancer       Date:  2014-02-26       Impact factor: 4.430

10.  Detection of three closely located single nucleotide polymorphisms in the EAAT2 promoter: comparison of single-strand conformational polymorphism (SSCP), pyrosequencing and Sanger sequencing.

Authors:  Shavanthi Rajatileka; Karen Luyt; Maggie Williams; David Harding; David Odd; Elek Molnár; Anikó Váradi
Journal:  BMC Genet       Date:  2014-07-05       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.